DVT Deep Vein Thrombosis, DICE Dynamic Integrated Climate-Economy model, healthcare, PICO framework, medical research, venous thromboembolism, pulmonary embolism, database
The use of the PICO(T) (Patient/Population and Intervention, Comparison, Outcome and Time) approach is essential when offering care to patients diagnosed with deep vein thrombosis (DVT), as it forms the cornerstone of the healthcare evidence-based decision-making process. These guidelines help healthcare workers to be able to ask simple questions progressively, target the applicable evidence, and translate the research outcomes into pragmatic, practice-oriented solutions sequentially. In addition to its central role in formalising the decision-making process, evidence-based methods also contribute to a more precise knowledge of the available landscape of evidence that may even be used to improve the patient's healthcare outcomes.
[...] (2020) provided clear and practical recommendations for managing DVT and PE. The protocol once more reiterated that direct oral anticoagulants (DOACs) are preferred most of the time over vitamin K antagonists (VKAs) due to their safety and efficacy profile. By integrating the results of clinical trials and experts' opinions, the guidelines have designed a decision scheme for practitioners regarding which anticoagulation strategy to select while considering variables such as the nature of the patient, comorbidities, and bleeding risk. This evidence-based approach has adopted a pathway to enhance patient outcomes while reducing the probability of thrombotic development and bleeding events. [...]
[...] (2021) highlights that what matters a lot in such conditions is being alert and proactive, involving early screening of the thrombotic health risks and individuals affected by COVID-19 in particular. In this situation, where PE and DVT are relatively common among patients, healthcare providers must be more vigilant and update diagnostic workup strategies to diagnose and manage thrombotic events promptly. Therefore, Ortel et al. (2020) supply clinicians with results that summarize the anticoagulation therapy options based on evidence that are significant in patients with DVT. [...]
[...] Deep venous thrombosis. Annals of Internal Medicine, 175(9), ITC129-ITC144. Kirkilesis, G., Kakkos, S. K., Bicknell, C., Salim, S., & Kakavia, K. (2020). Treatment of distal deep vein thrombosis. Cochrane Database of Systematic Reviews, Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A & Zhang, Y. (2020). [...]
[...] This guideline reduces the probability of over-treatment or under-treatment in people with similar situations, allowing healthcare professionals to modify the treatment plan for individual patients, assuring efficient and effective care. Conclusion Bearing in mind that implementing evidence-based practices concerning the treatment of deep vein thrombosis (DVT) means having a thorough understanding of the evidence base, it is an approach to implementation structured to suit the clinical context. The PICO(T) framework tries to provide a method for the systemic and organized development of the patient/population, intervention, comparison, outcome, and time questions. [...]
[...] It is also evident that the D-dimer tests are somewhat precise when it comes to detecting blood clots in patients with COVID-19. The meta-analysis synthesized data from different studies, enabling the group's work to provide a comprehensive overview of COVID-19's thrombotic risk and the diagnostic test utility in ensuring these complications are diagnosed. Furthermore, we have referred to a set of guidelines, the guidelines of the American Society of Hematology (Ortel et al., 2020), which help to make a scientifically based management of DVT and PE clearer. [...]
APA Style reference
For your bibliographyOnline reading
with our online readerContent validated
by our reading committee
